Sware

United States - Chelsea, Massachusetts

• 07/06/2024
• Series B
• $6,000,000

Sware is a tech-first company, transforming compliance in life sciences and supporting an industry-wide transition from an inefficient, manual approach to an automated, workflow-driven, data-centric solution. Sware delivers process automation and a single source of validation truth for customers who want ground-breaking results.

By driving the end-to-end validation process, Sware’s platform enables painless adoption of emerging technologies for healthcare, life sciences, and SaMD companies. With advanced technology and automation, Sware ensures consistency in compliance and keeps companies in a state of inspection readiness.

We have helped more than 275 healthcare and life sciences companies transition to the regulated cloud. With advanced technology and automation, Sware was founded by the same leaders who took Veeva Vault and the life sciences industry into the cloud. Today, we’re evolving to meet the needs of Validation 4.0 by instilling trust and quality in the new technologies of Pharma 4.0.

Validation to Sware by.

Related People

Ellen ReillyFounder

United States - New York City Metropolitan Area

Extensive leadership in the intersection of Technology, Data and Life Sciences & Healthcare. Exec Roles in SAAS Software, Manufacturing, Global Advisory and Consulting Organizations, and Data Provider. Experience at DocuSign, IQVIA and Whoop. Chair of Board Experience.

LinkedIn https://www.linkedin.com/in/ellen-reilly/